advisorsecurities master

KROSKeros Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
17828
Ticker
KROS
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-04-08
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
KROS

Detail

Enriched 2026-08-14 20:47

Market cap
$222,064,505.6
Shares outstanding (class)
19,827,188
Shares outstanding (weighted)
19,827,188
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
92
Location
LEXINGTON, MA
Description

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data